Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2023-01-01–present
Donald DeGolyer
Board Member
Emergent BioSolutions Inc. (EBS)Equibles does not estimate personal net worth.
About Donald DeGolyer
Donald DeGolyer is recorded as Board Member at Emergent BioSolutions Inc. (EBS) since January 1, 2023. The newest filing on record that lists Donald DeGolyer as Board Member at Emergent BioSolutions Inc. (EBS) is dated March 20, 2026. Emergent BioSolutions Inc. reported in an 8-K filed May 29, 2024 that Donald DeGolyer was appointed Class III director, effective May 23, 2024. Emergent BioSolutions Inc. reported in an 8-K filed October 2, 2023 that Donald DeGolyer was appointed Class III director, effective October 1, 2023. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
“All director nominees were elected and qualified.”
“On September 28, 2023, the Board of Directors (the "Board") of Emergent BioSolutions Inc. (the "Company") appointed Donald DeGolyer and Neal Fowler as Class III directors effective October 1, 2023, with initial terms expiring at the Company's 2024 annual meeting of stockholders.”
Affiliation history
-
Current
2023-01-01–present
Last confirmed March 20, 2026
Company network
Leadership on record at Emergent BioSolutions Inc.
- Daniel J. Abdun-Nabi CEO, COO, Board Member
- Joseph C. Papa CEO, Board Member
- Joseph Papa CEO, Board Member
- Robert G. Kramer, Sr. CEO, Board Member
- Zsolt Harsanyi Chairman, Board Member
- Frank Vargo CFO
- Richard S. Lindahl CFO
- Robert G. Kramer CFO
- Adam Havey COO
- Jessica Perl General Counsel